Although in cell line-based experiments, GNG4 abrogated both phospho-Erk and phospho-Jnk, but it is evident that in tumor scenario ERK pathway has a more pronounced role and hence is modulated to a greater extent by GNG4. The gene discussed is GNG4; the disease is neoplasm.